High dose intravenous immunoglobulin treatment: Mechanisms of action

被引：44
作者：
Boros, P
Gondolesi, G
Bromberg, AS
机构：
[1] Mt Sinai Sch Med, Recanati Miller Transplantat Inst, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY USA
来源：
LIVER TRANSPLANTATION | 2005年 / 11卷 / 12期
关键词：
D O I：
10.1002/lt.20594
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Intravenous immunoglobulin (IVIg) treatment was introduced as replacement therapy for patients with antibody deficiencies, but evidence suggests that a wide range of immune-mediated conditions could benefit from IVIg. The immunoglobulins are precipitated from human plasma by fractionation methods. In conclusion, the differences in basic fractionation methods and the addition of various modifications for purification, stabilization, and virus inactivation result in products significantly different from each other.
引用
收藏
页码：1469 / 1480
页数：12
相关论文
共 109 条
  • [1] ANTI-CYTOKINE NATURE OF NATURAL HUMAN-IMMUNOGLOBULIN - ONE POSSIBLE MECHANISM OF THE CLINICAL EFFECT OF INTRAVENOUS IMMUNOGLOBULIN THERAPY
    ABE, Y
    HORIUCHI, A
    MIYAKE, M
    KIMURA, S
    [J]. IMMUNOLOGICAL REVIEWS, 1994, 139 : 5 - 19
  • [2] Intravenous immunoglobulin and Thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients
    Akalin, E
    Ames, S
    Sehgal, V
    Fotino, M
    Daly, L
    Murphy, B
    Bromberg, JS
    [J]. TRANSPLANTATION, 2003, 76 (10) : 1444 - 1447
  • [3] Downregulation of TGF-β1 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin
    Amemiya, K
    Semino-Mora, C
    Granger, RP
    Dalakas, MC
    [J]. CLINICAL IMMUNOLOGY, 2000, 94 (02) : 99 - 104
  • [4] POOLED HUMAN-IGG MODULATES CYTOKINE PRODUCTION IN LYMPHOCYTES AND MONOCYTES
    ANDERSSON, U
    BJORK, L
    SKANSENSAPHIR, U
    ANDERSSON, J
    [J]. IMMUNOLOGICAL REVIEWS, 1994, 139 : 21 - 42
  • [5] ANDERSSON UG, 1993, IMMUNOLOGY, V79, P211
  • [6] Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B
    Angus, PW
    McCaughan, GW
    Gane, EJ
    Crawford, DHG
    Harley, H
    [J]. LIVER TRANSPLANTATION, 2000, 6 (04) : 429 - 433
  • [7] Cytomegalovirus immune globulin after liver transplantation: a cost-effectiveness analysis
    Arbo, MDJ
    Snydman, DR
    Wong, JB
    Goldberg, HS
    Schmid, CH
    Pauker, SG
    [J]. CLINICAL TRANSPLANTATION, 2000, 14 (01) : 19 - 27
  • [8] AUKRUST P, 1994, BLOOD, V84, P2136
  • [9] Ballow Mark, 2002, J Am Pharm Assoc (Wash), V42, P449, DOI 10.1331/108658002763316888
  • [10] BASTA M, 1991, BLOOD, V77, P376
12345678910